IL7R and multiple sclerosis: GSK2618960 is a humanized IgG1 monoclonal antibody directed against the alpha component (IL-7Rα; CD127) of TSLPR [153] and is being developed for the treatment of autoimmune diseases (including multiple sclerosis) [154].